KDM3B enforces a non-mutational ErbB signaling state that sustains cholangiocarcinoma
More than 50% of cholangiocarcinoma (CCA) patients lack druggable mutations, showing broad non-mutational epigenetic perturbations, whose mechanistic insig
More than 50% of cholangiocarcinoma (CCA) patients lack druggable mutations, showing broad non-mutational epigenetic perturbations, whose mechanistic insig